Real-World Evidence in HTA: Solving Bias and Privacy Challenges

The integration of real-world evidence in HTA is transforming how regulatory bodies and payers evaluate new medical interventions. As healthcare systems transition toward data-driven decision-making, ensuring the quality of non-randomized data becomes essential. However, researchers often encounter systematic errors when using electronic health records (EHR) and administrative claims. This update highlights a new framework designed to mitigate these information biases while protecting patient confidentiality.

Mitigating Information Bias in EHR Data

Information bias represents a significant threat to the validity of real-world evidence in HTA. Specifically, misclassification of disease status or missing data can lead to skewed clinical conclusions. A recent targeted review of literature from 2019 to 2024 offers fifteen practical recommendations to address these gaps. These guidelines focus on rigorous study design, precise variable definition, and advanced statistical analyses. Consequently, applying these methods helps researchers produce evidence that meets the high standards required for reimbursement approval.

Securing Privacy through Synthetic Data and Federated Networks

Beyond data quality, privacy remains a major hurdle for international research collaboration. Emerging privacy-preserving technologies (PETs), such as synthetic data, allow researchers to access diverse datasets across borders. Synthetic data replicates the statistical properties of actual patient populations without exposing individual identities. Furthermore, federated networks enable decentralized data analysis. Therefore, institutions can generate global insights without moving sensitive information from its original location. These innovations are critical for advancing health technology assessment while maintaining strict compliance with privacy regulations.

Frequently Asked Questions

How do researchers mitigate information bias in EHR?

Researchers use a combination of rigorous study design, validated variable definitions, and statistical bias adjustment methods. These steps ensure that the data accurately reflects patient outcomes and treatment effects.

What are the benefits of federated networks in healthcare?

Federated networks allow multiple institutions to analyze data collaboratively without centralizing individual patient records. This approach protects privacy while enabling large-scale research across different regions.

Can synthetic data replace real-world data?

Synthetic data mimics the patterns of real-world data for research and AI training. While it is excellent for privacy-preserving analysis, it typically supplements rather than fully replaces original patient records in clinical validation.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Arora P et al. R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 26. J Comp Eff Res. 2026 May 05. doi: 10.57264/cer-2026-0074. PMID: 42083917.


2. Wang EH et al. Crossing borders securely: synthetic data and federated networks for privacy-preserving access to real-world data and emerging use cases. NPJ Digit Med. 2025 Dec 15;8(1):758. doi: 10.1038/s41746-025-02126-8.


3. ResearchGate. Information Bias in Electronic Health Records and Administrative Claims Data: A Targeted Review of the Recent Literature. Published Jan 2026. Accessed May 05, 2026.